How is Zilretta administered?
Official answer
by Drugs.comZilretta (triamcinolone acetonide extended-release injectable suspension) is administered as an intra-articular injection into the knee joint.
Zilretta is indicated for the management of osteoarthritis pain of the knee.
Zilretta contains triamcinolone acetonide, a commonly administered, short-acting corticosteroid formulated in poly lactic-co-glycolic acid (PLGA) microspheres to provide long acting pain relief over 12 weeks.
Zilretta works by reducing inflammation to decrease acute episodes of pain and increase joint mobility.
Common side effects of Zilretta include joint pain, headache, joint swelling, back pain, sore throat and runny nose, upper respiratory tract infection, and bruising.
Related medical questions
- What causes Plaque Psoriasis?
- Clobetasol vs. triamcinolone - how do they compare?
- Can triamcinolone acetonide B be used to treat severe diaper rash on a little girl?
- Halobetasol vs triamcinolone: which is better?
- How to sleep while taking Cymbalta?
- What's the difference between osteoporosis, osteopenia and osteoarthritis?
- Osteoporosis FAQs: Your Top Questions Answered
Drug information
- Zilretta Information for Consumers
- Zilretta Information for Healthcare Professionals (includes dosage details)
- Side Effects of Zilretta (detailed)
Related support groups
- Zilretta (2 questions, 6 members)
- Osteoarthritis (170 questions, 824 members)